Feng, Wen-Huan <br/><br/>
Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial.  [electronic resource] 

 -  Journal of diabetes investigation  Mar 2019 
 - 399-407 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2040-1124 
<br/><br/><label>Standard No.: </label>10.1111/jdi.12888  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers--analysis<br/>Blood Glucose--analysis<br/>Body Composition--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Gliclazide--therapeutic use<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Liraglutide--therapeutic use<br/>Liver Function Tests<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Non-alcoholic Fatty Liver Disease--drug therapy<br/>Prognosis<br/>Prospective Studies<br/>Young Adult